Accelerate the discovery of genetic variants in mitochondrial diseases with Variant prIOritization using Latent spAce
Briefings in Bioinformatics · 2025
DOI: 10.1093/bib/bbaf612 ↗Kurz gefasst
Fachartikel in der Zeitschrift Briefings in Bioinformatics, 2025. Verfasst von Justine Labory und 6 weiteren Autor:innen. Beteiligte Einrichtung: Université Côte d'Azur, Inserm U1081, CNRS UMR 7284, Institute for Research on Cancer and Aging Nice (IRCAN), 28, Ave de Valombrose, 06107 Nice Cedex…. Hauptthemen laut MEDLINE: Mitochondrial Diseases, Genetic Variation. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Agence Nationale pour la Recherche, French Foundation For Rare Disease, National Research Agency.
Abstract (Originalsprache)
Interpreting variants from whole-exome sequencing remains a major challenge, particularly for heterogeneous disorders such as mitochondrial diseases (MDs). To address this, we have developed Variant prIoritizatiOn using Latent spAce (VIOLA), a pipeline designed to help find a diagnosis for complex cases. VIOLA uses a variational autoencoder to embed functional annotations into a low-dimensional space, followed by DBSCAN-based outlier detection to identify potential pathogenic variants. Filtering steps and phenotype integration via HPO terms are then applied. The VIOLA score (Vscore) combines variant outlierness, transcriptomic co-expression data, and MD-specific annotations. Two rankings are derived: the VIOLA rank (all variants) and the ARrank (variants compatible with autosomal recessive inheritance). The VIOLA Aggregated score (VAscore) merges Vscore with Exomiser’s pathogenicity score. Applied to 20 patients (four diagnosed), VIOLA reduced the variant list by >99% and ranked causal variants within the top 5 using ARrank, outperforming existing methods. Overall, VIOLA is a patient-specific strategy for variant prioritization, helping to resolve challenging MD cases and uncover novel disease mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Université Côte d'Azur, Inserm U1081, CNRS UMR 7284, Institute for Research on Cancer and Aging Nice (IRCAN), 28, Ave de Valombrose, 06107 Nice Cedex 02, France.
- INRAE, Université Côte d'Azur CNRS, Institut Sophia Agrobiotech, 400 route des chappes, BP 167 06903 Sophia Antipolis Cedex, France.
- House of modeling, simulations and interactions, Université Côte d'Azur, Parc Valrose - 28, avenue Valrose Nice Cedex 2 06108, France.
- Department of Medical Genetics, Reference Centre for Mitochondrial Diseases Centre Hospitalier Universitaire (CHU) de Nice, 151 Route de Saint-Antoine, 06200 Nice, France.
ORCID-Profile: Silvia Bottini
Förderung
- Agence Nationale pour la Recherche
- French Foundation For Rare Disease
- National Research Agency
Zitieren
APA
Labory, J., Boulaimen, Y., Singh, J., Ait-El-Mkadem Saadi, S., Paquis-Flucklinger, V., Bannwarth, S., & Bottini, S. (2025). Accelerate the discovery of genetic variants in mitochondrial diseases with Variant prIOritization using Latent spAce. Briefings in Bioinformatics. https://doi.org/10.1093/bib/bbaf612
Vancouver
Labory J, Boulaimen Y, Singh J, Ait-El-Mkadem Saadi S, Paquis-Flucklinger V, Bannwarth S, et al. Accelerate the discovery of genetic variants in mitochondrial diseases with Variant prIOritization using Latent spAce. Briefings in Bioinformatics. 2025. doi:10.1093/bib/bbaf612
BibTeX
@article{Labory2025,
author = {Labory, Justine and Boulaimen, Youssef and Singh, Jasmine and Ait-El-Mkadem Saadi, Samira and Paquis-Flucklinger, Véronique and Bannwarth, Sylvie and Bottini, Silvia},
title = {Accelerate the discovery of genetic variants in mitochondrial diseases with Variant prIOritization using Latent spAce},
journal = {Briefings in Bioinformatics},
year = {2025},
doi = {10.1093/bib/bbaf612}
}
EUVIMED